Equites Radar

PBH · Prestige Consumer Healthcare In

Drug Manufacturers - Specialty & GenericUnited StatesAnalyst view: none

$47.26

-0.17% last session

End-of-day data · close of 2026-09-11

Bearish0 bullish · 5 bearish technical signals
To mean target: +43.2%

Market cap

$2B

Enterprise value

$4B

Trailing P/E

13.6

Forward P/E

9.3

Dividend yield

Beta

0.33

Avg volume

1M

Employees

1K

Daily Change %

-0.17%

5 Days Change

-6.81%

10 Days Change

-5.95%

30 Days Change

-9.14%

60 Days Change

-0.41%

Month to Day Change

-7.48%

Year to Day Change

-21.06%

Analyst Outlook

Consensus rating
Recommendation mean (1–5)
Covering analysts5
Mean price target$67.80
Low price target$55.00
Upside to mean target+43.2%

Analyst estimates change daily — follow the shifts on the Estimate Trends page.

Technical Analysis

RSI (14)34.6
50-day MA$50.74
200-day MA$56.58
Price vs 50-day MA-6.9%
Price vs 200-day MA-16.5%
MACD histogram-0.61
Volume vs 3-month avg0.4×
52w low $45.4452w high $70.21

Analyst sentiment over time — PBH

Rec Mean (blue, left — higher = more bullish) vs. price targets (right).

Investment Bank Ratings as of 2026-05-15

Latest call per bank · past 12 months

Jefferies

Hold

$66.00

+39.4% vs price
▼ cut from $70.00Maintains · 2026-02-02

Recent rating actions

DateFirmActionRatingPrice target
2026-05-15Canaccord GenuityMaintainsBuy$86.00 $72.00
2026-05-14OppenheimerDowngradeOutperformPerform$0.00
2026-05-07OppenheimerMaintainsOutperform$77.00 $65.00
2026-02-02JefferiesMaintainsHold$70.00 $66.00
2025-11-07Canaccord GenuityMaintainsBuy$100 $88.00
2025-10-27JefferiesMaintainsHold$75.00 $71.00
2025-10-21OppenheimerMaintainsOutperform$82.00 $72.00

Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.

Signal Summary as of 2026-09-11

  • RSI (14): RSI is 35 — neutral momentum, neither overbought nor oversold.
  • Price vs 50-day MA: Trading 6.9% below the 50-day MA ($50.74).
  • Price vs 200-day MA: Trading 16.5% below the 200-day MA ($56.58).
  • MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
  • MACD (12,26,9): MACD histogram is negative (-0.61) — short-term momentum is fading.
  • 52-week range: Price is within 10% of the 52-week low ($45.44).

PBH Price Chart

Loading chart for PBH

Fundamentals

Revenue (TTM)$1.0B
EBITDA$0M
Free cash flow$0M
Operating cash flow$0M
Book value / share$40.46
Net Debt / EBITDA6.1
WACC6.0%
Revenue growth6.00%
Earnings growth-36.00%

About Prestige Consumer Healthcare In

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under the Debrox brand name. It also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; motion sickness relief products under the Dramamine brand; enemas and other laxative products under the Fleet brand name; stomach upset remedies under the Gaviscon brand; cough drops under the Luden's brand; products for yeast infections in women under the Monistat brand name; lice and parasite treatments under the Nix name; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; products for dry eyes under the TheraTears brand; nasal saline sprays and washes under the Fess brand name; and oral rehydration products under the Hydralyte brand. It sells its products to mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

More in Drug Manufacturers - Specialty & Generic

Screen PBH against the full market on the Radar →

Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.